Previous product
Back to products
Padcev (enfortumab vedotin-ejfv)
CHF5,350.80
Next product
Ayvakit (avapritinib)
CHF45,500.00
Elzonris (tagraxofusp-erzs)
CHF34,243.95
Elzonris (tagraxofusp-erzs) is a medication used to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years and older.
Category: Oncology
Reviews
There are no reviews yet.